Section Summary
- HS is a chronic inflammatory disease expressed across time, not simply a series of isolated boils.
- Diagnostic delay remains common and may be reinforced by misdiagnosis, fragmented care, delayed referral, and patient embarrassment.
- Recurrent inflammation can contribute to tunnels and scarring, but progression is not inevitable and individual trajectories vary.
- Pain, drainage, odor, functional impairment, and psychosocial effects may accumulate before extensive structural disease is visible.
- Earlier recognition enables disease-specific education, longitudinal assessment, appropriate referral, and timely reconsideration of ineffective care.
| Key Takeaway: Recognizing clinically meaningful HS earlier may reduce years of repeated acute care and create an opportunity to address inflammation and patient burden before additional irreversible structural damage develops. |
This content is sponsored but developed independently with Steven Daveluy, MD, Dermatologist.